Answers are grounded in this paper and cite their sources.
Small-molecule recognition of bacterial metabolic enzymes can perturb bacterial physiology, yet how such interactions translate into antibacterial activity remains poorly understood. Herein, we identify equisetin (EQ), a fungal meroterpenoid, as a potent anti-MRSA natural product with pronounced antibiofilm activity and a low propensity for resistance development. EQ induced membrane dysfunction, ATP depletion, reactive oxygen species (ROS) accumulation, and ultrastructural damage. Transcriptomics and qRT-PCR implicated perturbation of pentose phosphate pathway (PPP)-associated redox metabolism, accompanied by reduced gndA transcript levels and 6-phosphogluconate dehydrogenase (6PGD) abundance. Isothermal titration calorimetry demonstrated direct micromolar EQ-6PGD binding, while molecular docking suggested a plausible binding mode. In an MRSA-infected murine wound model, EQ reduced bacterial burden and accelerated tissue repair. Collectively, these findings suggest that membrane dysfunction and PPP-associated redox metabolic perturbation may jointly contribute to EQ-mediated antibacterial activity, identifying 6PGD-associated PPP redox metabolism as a chemically exploitable vulnerability in MRSA.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: